|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Daclizumab,a humanized antrinterleukin-2 receptor alpha chain antibody,for treatment of acute graft-versus-host disease显示文摘 | Pzepiorka D Keman NA Ippoliti C | 2000 | Am soci Hematol2000，95，： | 1 |
| 2 | Daclizumab, a humanized anti- interleukin- 2 receptor alpha chain antibody,for treatment of acute graft - vs - host disease显示文摘 | Przepiorka D Keman NA Ippoliti C | 2000 | Blood2000，95，： | 1 |
| 3 | In vitro interferongamma production by cultured T-cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to antithymocyte globulin显示文摘 | Laver J Castro Malaspina H Keman NA | 1988 | Br J Haematol1988，69，： | 1 |
| 4 | Differential effect of pre-transplant cytoreduction on recovery of day zero host circu- lating cells显示文摘 | Papadakis V Mackinnon S Keman NA | 1994 | Bone Marrow Transplant1994，14，4： | 1 |
| 5 | Umbilical cord blood infusion in a patient for correction of Wiskott - Aldrich syndrome 显示文摘 | Keman NA Schroeder ML Ciavarella D | 1994 | Blood Cells1994，20，23： | 1 |
| 6 | Allogeneic sibling umbilical cord blood transplantation in forty-four children with malignant and non-malignant disease显示文摘 | Wagner JE Keman NA Steinbuch M | 1995 | Lancet1995，346，7： | 1 |
| 7 | Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody,for treatment of acute graft-versus-host diseases显示文摘 | Keman NA Ippoliti C | 2000 | Am Soci Hemotol2000，95，： | 1 |
| 8 | Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease 显示文摘 | KEMAN NA IPPOLITI C | 2000 | Blood2000，95，1： | 1 |
| 9 | Busulfan/melphalan/Antithymocyto globulin followed unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children:the cord blood transplantation study(COBLT) experience 显示文摘 | Wall DA Carter SL Keman NA Kapoor N Kamani NR Brochstein SA | 2005 | Biol Blood Marrow Transplant2005，11，8： | 1 |
| 10 | Daclizumab, ahumanized anti-interleukin-2 receptor alpha chain antibody, fortreatment of acute graft-versus-host disease显示文摘 | Przepiorka D Keman NA Ippoliti C | 2000 | Blood2000，95，1： | 1 |
| 11 | Clonable T lymphocytes in T cell - depleted bone marrow transplants correlate with development of graft - v - host disease 显示文摘 | Keman NA Collins NH Juliano L | 1986 | Blood1986，68，3： | 1 |
| 12 | Successful treatment of metastatic retinoblastoma 显示文摘 | DUNKEL LI ALEDOA KEMAN NA | 2000 | Cancer2000，89，： | 1 |
| 13 | Daclizumab,a humanized Anti-interleukin-2 receptor alpha chain antibody,for treatment of acute Graft-versus-host disease显示文摘 | Przepiorka D Keman NA Ippoliti C | | 0，，01： | 1 |
| 14 | Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemla'and leukemia in young children: The Cord Blood Transplantation study (COBLT) experience显示文摘 | Wall DA Carter SL Keman NA | 2005 | Biol Blood Marrow Transplant2005，11，8： | 1 |
| 15 | Results of the cord blood transplantation study (COBLT) : Outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases 显示文摘 | Martin PL Carter SL Keman NA | 2006 | Biol Blood Marrow Transplant2006，12，2： | 1 |
| 16 | Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute-versus-host disease 显示文摘 | Przepiorka D Keman NA Ippoliti C | 2000 | Blood2000，95，1： | 1 |
| 17 | Daclizumab,a humanized anti-interleukin-2 receptor alpha chain antibody,for treatment of acute graft-versus-host disease显示文摘 | Przepiorka D Keman NA Ipploiti C | | 0，，01： | 1 |
| 18 | The probability of HLA-C matching between patient and unrelated donor at the molecular level:estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles显示文摘 | Heller G Keman NA | 1999 | Transplantation1999，68，7： | 1 |
| 19 | 显示文摘 | Pasad VK Heller G Keman NA | 1999 | Transplantation1999，68，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员